KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Change in Cash: 2010-2024

Historic Change in Cash for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to $732,000.

  • TherapeuticsMD's Change in Cash rose 665.41% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 140.40%. This contributed to the annual value of $732,000 for FY2024, which is 101.63% up from last year.
  • Per TherapeuticsMD's latest filing, its Change in Cash stood at $732,000 for FY2024, which was up 101.63% from -$45.0 million recorded in FY2023.
  • In the past 5 years, TherapeuticsMD's Change in Cash registered a high of $732,000 during FY2024, and its lowest value of -$80.3 million during FY2020.
  • In the last 3 years, TherapeuticsMD's Change in Cash had a median value of -$15.8 million in 2022 and averaged -$20.0 million.
  • Per our database at Business Quant, TherapeuticsMD's Change in Cash tumbled by 10,161.05% in 2020 and then surged by 101.63% in 2024.
  • Yearly analysis of 5 years shows TherapeuticsMD's Change in Cash stood at -$80.3 million in 2020, then skyrocketed by 80.88% to -$15.4 million in 2021, then dropped by 2.87% to -$15.8 million in 2022, then slumped by 184.66% to -$45.0 million in 2023, then soared by 101.63% to $732,000 in 2024.